Stillo A, Bianco V, Lorenzin M G, Franzosi N
Ann Ostet Ginecol Med Perinat. 1989 Nov-Dec;110(6):296-304.
The Authors report the results of a controlled clinical study by means of colposcopy, cytology and target biopsy on 525 oral contraceptive (O.C.) users and 519 controls. Except for age class 31-35, more iodine dark cervices are found in cases, more iodine light (AnTZ and/or ectropion) in controls. The difference, although not statistically significant, suggests a protective role of O.C. on cervical epithelia. In 34 women (15 cases and 19 controls) CIN has been diagnosed. O.C. users show a more favorable situation, except for ages over 30 exposed to O.C. for less than 24 months. The Authors hypothesize a protective role of O.C. in younger women. While women aged 30 or more still appear protected when exposed to O.C. for more than two years (possibly from younger ages), these results suggest some caution in beginning oral contraception after the 30th year of age.
作者报告了一项对照临床研究的结果,该研究通过阴道镜检查、细胞学检查和靶向活检,对525名口服避孕药(O.C.)使用者和519名对照者进行了研究。除了31 - 35岁年龄组外,病例组中发现碘着色深的宫颈更多,对照组中碘着色浅(醋酸白色上皮和/或外翻)的宫颈更多。这种差异虽然无统计学意义,但提示口服避孕药对宫颈上皮有保护作用。在34名女性(15例病例和19名对照)中诊断出了宫颈上皮内瘤变(CIN)。口服避孕药使用者的情况更有利,但30岁以上且服用口服避孕药少于24个月的女性除外。作者推测口服避孕药对年轻女性有保护作用。虽然30岁及以上的女性在服用口服避孕药两年以上(可能从较年轻时开始)时似乎仍受到保护,但这些结果表明30岁以后开始口服避孕药时需谨慎。